Antonius Berkien

Antonius Berkien

Corporate Officer/Principal chez CANTARGIA AB

Fortune : 12 613 $ au 31/05/2026

58 ans
Health Technology
Commercial Services
Finance

Profil

Antonius Berkien is currently the Chairman at Gedea Biotech AB, the Director at Nordic Pharma Licensing Group, the Senior Manager at Rijnconsult BV, the Senior Manager at KPMG Danmark A, the Chief Business Officer at Ultimovacs ASA since 2020, and the Chief Business Officer at Cantargia AB since 2024.
Previously, he worked as the Director-Global Business Development at Amgen, Inc., the Director-Competitive Intelligence at Ferring Pharmaceuticals A from 2003 to 2007, the Senior Director-Corporate Development at Takeda A from 2007 to 2013, and the Senior Manager at PricewaterhouseCoopers (Denmark) from 2001 to 2003.
He also served as the Chief Business Officer at Nuevolution AB. Mr. Berkien obtained his undergraduate degree from Saxion University of Applied Sciences.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/12/2024 53 423 ( 0,02% ) 12 613 $ 31/05/2026

Postes actifs de Antonius Berkien

SociétésPosteDébut
CANTARGIA AB Corporate Officer/Principal 01/10/2024
Corporate Officer/Principal -
Nordic Pharma Licensing Group
Directeur/Membre du Conseil -
Président -

Anciens postes connus de Antonius Berkien

SociétésPosteFin
Corporate Officer/Principal 18/07/2016
Corporate Officer/Principal 01/01/2007
Corporate Officer/Principal 01/01/2003
AMGEN INC. Corporate Officer/Principal -
Corporate Officer/Principal -
Voir l'expérience en détail de Antonius Berkien

Formation de Antonius Berkien

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

7

Relations au 1er degré

12

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées12

Health Technology

Health Technology

Commercial Services

Finance

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Nordic Pharma Licensing Group

Commercial Services

  1. Bourse
  2. Insiders
  3. Antonius Berkien
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT